Long-term efficacy and safety of ustekinumab, with

and without dosing adjustment, in patients with

moderate-to-severe psoriasis: results from the PHOENIX 2

study through 5 years of follow-up

in this study what is meant by PHOENIX 1 and PHOENIX 2 study?

Similar questions and discussions